Search results
How one state is trying to make weight loss drugs cheaper
NBC News via Yahoo News· 7 days agoWeight loss drugs aren't covered by insurance for North Carolina's state employees. The state is...
Chuck Todd: The race to build a better internet — before it's too late
NBC News via Yahoo News· 7 hours agoWe will install cameras and other monitoring systems in every room of your house, including your...
How to Invest in a ‘Higher for Longer’ Rate Backdrop
Barrons.com· 5 hours agoIt has never been a cheap stock, but it’s now trading well below its five-year average multiples. CFRA analyst Michael Elliott expects shares to reach...
Cencora stock down premarket as company reports bottom-line miss in Q1 By Investing.com
Investing.com· 6 hours agoCencora, Inc. (NYSE: COR) today reported Q1 EPS of $3.28, $0.42 worse than the analyst estimate of...
MeVis Medical Solutions (ETR:M3V) investors are sitting on a loss of 13% if they invested three...
Simply Wall St. via Yahoo Finance· 3 days agoGenerally speaking long term share price weakness...investment risk. We've identified 4 warning...
These lifestyle gyms aren't competing with Ozempic — they're embracing it
Quartz· 3 days agoOzempic, Wegovy, and Zepbound are all GLP-1 (glucagon-like peptide 1) agonists, a type of drug that...
Sanders launches investigation into ‘unacceptable’ diabetes, weight loss drug prices
The Hill via AOL· 7 days agoHealth, Education, Labor, and Pensions (HELP) Committee, launched an investigation Wednesday into...
Cencora stock down premarket as company reports bottom-line miss in Q1
Investing.com· 13 hours agoCencora, Inc. (NYSE: COR) today reported Q1 EPS of $3.28, $0.42 worse than the analyst estimate of...
These Are The 5 Best Stocks To Buy And Watch Now
Investor's Business Daily· 18 hours agoBuying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So which are the best stocks to buy now or put on a...
Cencora (COR) Q2 Earnings Top Estimates, 2024 View Raised
Zacks via Yahoo Finance· 5 hours agoCencora's (COR) second-quarter fiscal 2024 results benefit from overall market growth, including...